# A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, Food Effects, and Drug-drug Interactions of ACP-196 in Healthy Participants

> **NCT04901923** · PHASE1 · COMPLETED · sponsor: **Acerta Pharma BV** · enrollment: 59 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** ACP-196
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT04901923
- **Lead sponsor:** Acerta Pharma BV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-15
- **Primary completion:** 2014-05-22
- **Final completion:** 2014-05-22
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2021-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04901923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04901923, "A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, Food Effects, and Drug-drug Interactions of ACP-196 in Healthy Participants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04901923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*